Literature DB >> 9919421

Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-alpha.

R Voisard1, M Osswald, R Baur, U Jakob, M Susa, T Mattfeldt, W Hemmer, A Hannekum, W Koenig, V Hombach.   

Abstract

BACKGROUND: The intercellular adhesion molecule-1 (ICAM-1) is one of several human cell adhesion molecules that play a critical role in the early stages of postangioplasty restenosis. In this study, the in-vitro expression of ICAM-1 in human coronary endothelial cells and human coronary smooth muscle cells (SMC) after stimulation with tumor necrosis factor-alpha (TNF-alpha) was investigated. METHODS AND
RESULTS: SMC were isolated from the media of normal human coronary arteries (n = 26) up to 10 h post mortem (HCMSMC) and from human atherosclerotic coronary arteries (HCPSMC) that were extracted by thrombendarterectomy (n = 25). Endothelial cells of human coronary arteries (HCAEC) were purchased from Clonetics (Cell System, Remagen, Germany), and endothelial cells from human umbilical cord veins (HUVEC) were isolated after vaginal delivery. For investigations of the effect of TNF-alpha (2.5, 5, 10, and 20 ng/ml) on the proliferative activity of HUVEC, HCAEC, HCPSMC, and HCMSMC, serum-free media was used. After 24 h cell number and cell size distribution were measured in a cell analyzer system. The proliferation of HCPSMC and HCMSMC was increased by TNF-alpha; however, significant differences compared with controls were not reached. The proliferation of HUVEC and HCAEC was significantly reduced by TNF-alpha. For investigations of the effect of TNF-alpha (2.5, 5, 10, and 20 ng/ml) on the surface expression of ICAM-1, monoclonal anti-ICAM-1 antibodies (84H10) were used. The expression of ICAM-1 was analyzed using an immunofluorescence microscope. For flow cytometry analysis, 5 x 10(3) cells (100% gated) were analyzed using a fluorescence-activated cell sorter. In control cultures with no stimulation, the expression of ICAM-1 was positive in HCAEC, HCPSMC, HCMSMC, and HUVEC. TNF-alpha stimulated the expression of ICAM-1 in a time- and dose-dependent manner. After maximal stimulation with TNF-alpha (20 ng/ml for 24 h), the expression of ICAM-1 was stronger in HCMSMC than in HCPSMC.
CONCLUSIONS: These results suggest that the cytokine TNF-alpha regulates the expression of ICAM-1 in both human coronary endothelial cells and SMC, and could therefore play an important role in the pathophysiology of inflammatory and immune processes in restenosis after angioplasty.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9919421     DOI: 10.1097/00019501-199809110-00006

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  5 in total

1.  Human solCD39 inhibits injury-induced development of neointimal hyperplasia.

Authors:  J H F Drosopoulos; R Kraemer; H Shen; R K Upmacis; A J Marcus; E Musi
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

2.  HUVECs from newborns with a strong family history of myocardial infarction overexpress adhesion molecules and react abnormally to stimulating agents.

Authors:  A Paez; A R Méndez-Cruz; E Varela; E Rodriguez; J Guevara; L Flores-Romo; L F Montaño; F A Massó
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio.

Authors:  Rainer Voisard; Mustafa Alan; Lutz von Müller; Regine Baur; Vinzenz Hombach
Journal:  BMC Cardiovasc Disord       Date:  2006-04-04       Impact factor: 2.298

4.  Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells.

Authors:  R Voisard; N Huber; R Baur; M Susa; O Ickrath; A Both; W Koenig; V Hombach
Journal:  BMC Mol Biol       Date:  2001-08-08       Impact factor: 2.946

5.  Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratios.

Authors:  Rainer Voisard; Svenja Zellmann; Fabian Müller; Felicitas Fahlisch; Lutz von Müller; Regine Baur; Jürgen Braun; Jürgen Gschwendt; Margaratis Kountides; Vinzenz Hombach; Joachim Kamenz
Journal:  BMC Cardiovasc Disord       Date:  2007-05-11       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.